Impact of age and gender disparity on CD4+ cell counts to control disease progression using specific HAART in HIV-1 positive patients: A case-control study
CONCLUSION: The administration of specific HAART (NRTIs and novel protease inhibitors) in HIV patients had a notable improvement in the CD4+ cell count and viral load with significant age and gender disparity.PMID:35980078 | DOI:10.2174/1574887117666220817123002
Source: Reviews on Recent Clinical Trials - Category: Cancer & Oncology Authors: Aakansha Singh Manoj Kumar Ashok K Singh Neeraj Verma Source Type: research
More News: Allergy & Immunology | Cancer & Oncology | Clinical Trials | Highly Active Antiretroviral Therapy | Prezista | Statistics | Study | Virology